Skip to main content

#151869

Anti-LRAT [M34-P1F10]

Cat. #151869

Anti-LRAT [M34-P1F10]

Cat. #: 151869

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: Lecithin Retinol Acyltransferase (LRAT)

Class: Monoclonal

Application: ELISA ; IHC ; IF ; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Ayham Alnabulsi

Institute: Vertebrate Antibodies Limited

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-LRAT [M34-P1F10]
  • Cancer: Digestive / Gastrointestinal cancer
  • Cancers detailed: Colorectal
  • Research fields: Cell signaling and signal transduction;Metabolism;Neurobiology
  • Clone: M34-P1F10
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Strain: Balb/c
  • Reactivity: Human
  • Host: Mouse
  • Application: ELISA ; IHC ; IF ; WB
  • Description: LRAT is significantly overexpressed in colorectal cancer and significantly associated with prognosis.
  • Immunogen: Peptide Sequence - RDQRSVLASA (amino acids 190 -199)
  • Isotype: IgG1
  • Recommended controls: ELISA- Peptide immunogenWestern Blot- Overexpression lysate Immunofluorescence- Hela Cells IHC- Human colon carcinoma

Target Details

  • Target: Lecithin Retinol Acyltransferase (LRAT)
  • Tissue cell line specificity: ELISA- Peptide immunogenWestern Blot- Overexpression lysate Immunofluorescence- Hela Cells IHC- Human colon carcinoma
  • Target background: LRAT is significantly overexpressed in colorectal cancer and significantly associated with prognosis.

Applications

  • Application: ELISA ; IHC ; IF ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

References

  • Brown et al. 2014. PLoS One. 9(3):e90776. PMID: 24608339.
  • The expression and prognostic significance of retinoic acid metabolising enzymes in colorectal cancer.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.